Factors of ACS atorvastatin on blood lipid levels, serum inflammatory

Fait T, Vrablik M. Coronary heart disease and hormone replacement therapy-from primary and secondary prevention to the window of opportunity [J]. Neurons Endocrinol Lett, 2012(2):17.

Sever P S, Poulter N R, Mastorantonakis S. Coronary heart disease benefits from blood pressure and lipid-lowering [J]. International Journal of Cardiology, 2009(2):218.

李斌, 张奇峰. 阿托伐他汀对老年急性冠脉综合征患者血脂、血清炎症因子和心脑血管事件的影响 [J]. 中国老年学杂志, 2013(2):569.doi: 10.3969/j.issn.1005-9202.2013.03.010.

黄璟, 熊龙根, 李国强. 阿托伐他汀与辛伐他汀对急性冠脉综合征血脂、高敏C反应蛋白和心室重构的影响 [J]. 广东医学, 2012(2):478.

Takagi H, Umemoto T. Low-density lipoprotein cholesterolindependent effects of statins on coronary artery disease [J]. American Journal of Cardiology, 2011(2):336.

陈丽珠, 马江伟, 孙淑艳. 不同剂量阿托伐他汀对急性冠脉综合征经皮冠状动脉介入术后血清单核细胞趋化蛋白-1和超敏C反应蛋白的影响 [J]. 中国全科医学, 2010(2):528.doi: 10.3969/j.issn.1007-9572.2010.06.019.

Munir J A, Wu H, Bauer K, Bindeman J. Impact of coronary calcium on arterial age and coronary heart disease risk estimation using the MESA arterial age calculator [J]. Atheroclerosis, 2010(2):467.

Marcus E.Kleber, Wilfried Renner, Tanja B.Grammer. Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction:The Ludwigshafen Risk and Cardiovascular Health Study [J]. Atheroclerosis, 2010(2):492.

吴涛, 邱健, 肖华. 不同剂量阿托伐他汀对急性冠脉综合征患者介入治疗后炎症及凝血因子的影响 [J]. 广东医学, 2011(2):463.doi: 10.3969/j.issn.1001-9448.2011.23.012.

李军, 杨慧玲. 阿托伐他汀对急性冠脉综合征患者介入治疗后血清IL-6、hs-CRP及血脂的影响 [J]. 中国老年学杂志, 2011(2):332.